Research Article
Identification of Potential Therapeutic Targets in the Liver of Pioglitazone-Treated Type 2 Diabetes Sprague-Dawley Rats via Expression Profile Chip and iTRAQ Assay
Figure 4
GO analysis of differentially expressed genes after treatment with pioglitazone. Microarray assay results of the DM model group and the pioglitazone-treated group. (a) Biological process. (b) Cellular component. (c) Molecular function.
(a) |
(b) |
(c) |